OCGN
OcugenยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
OCGN Profile
Ocugen, Inc.
A clinical-stage biopharmaceutical company that developing therapies to treat the eye diseases
11 Great Valley Parkway, Malvern, Pennsylvania 19355
--
Ocugen, Inc., was incorporated on June 28, 2000 under the federal laws of Massachusetts and conducts its principal business operations in Waltham, Massachusetts. The company is a biotechnology company focused on discovering, developing and commercializing novel gene and cell therapies and vaccines that can improve health and bring hope to patients around the world.
